Heart pump patients: does routine leg tube prevent limb loss?

NCT ID NCT07482865

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether routinely placing a small tube in the leg artery (distal perfusion catheter) is better than waiting until a problem arises in patients on mechanical heart pumps. About 500 adults with severe heart failure or shock will be randomly assigned to one of the two approaches. The main goal is to see which strategy reduces the risk of serious leg complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Distal perfusion catheter insertion (a small tube placed in the leg artery to keep blood flowing)
What this could lead to
If routine placement works better, it could become standard practice to prevent leg complications in patients on heart pumps.
What could go wrong
This is an early-stage trial (not yet recruiting) with no phase assigned, so results are uncertain. The procedure itself carries risks like bleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LIMB ISCHEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Eunpyeong St. Mary's Hospital

    Seoul, South Korea

  • Gyeongsang National University Changwon Hospital

    Changwon, South Korea

  • Korea University Anam Hospital

    Seoul, South Korea

  • Kwandong University Intl. ST. Mary's Hospital

    Incheon, South Korea

  • Samsung Medical Center

    Seoul, 06351, South Korea

  • Samsung Medical Center Changwon Hospital

    Changwon, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.